MD
Department of Clinical Pathology, Coimbra Hospital and Universitary Centre, Portugal
Coimbra, Coimbra, Portugal
João Mariano Pego, MD, Clinical Pathologist, Head of the Hemostasis Laboratory, Centro Hospitalar e Universitário de Coimbra
Personal Information:
João Mariano Pego
Relevant Qualifications:
MD, Clinical Pathologist
Current Function:
Head of the Hemostasis Laboratory, Clinical Pathology Department, Centro Hospitalar
e Universitário de Coimbra
Expert of International Council for Standardization in Haematology
Expert of Sociedad Española De Trombosis Y Hemostasia
President of AMELAB - Associação de Medicina Laboratorial para Formação e Inovação
Board of Directors of the Portuguese Society of Clinical Pathology
Board of Directors, Center Regional Council, Portuguese Medical Association
Director CMLGS Coimbra Laboratory
PhD candidate, Faculty of Medicine, Universidade de Coimbra
Editor of the Journal Medicina Laboratorial
President of the XIII National Congress of Clinical Pathology
Member of the hematology group of the Portuguese Society of Clinical Pathology
Most Relevant International Award:
2021 Eberhard F. Mammen Excellence in Thrombosis and Haemostasis Most Popular
Article Award
Most Relevant International Publications:
"Cardioembolic stroke in a patient taking Dabigatran Etexilate: the first case report of
clinical and pharmacological resistance";
"International Council for Standardization in Haematology (ICSH) Recommendations
for Coagulation Critical Values and Reporting"
Most Relevant International Invited Lectures:
"Body fluids", ISLH 2018;
"Lp-PLA2 level - Association with the acute coronary syndrome and the thrombotic
burden", Euromedlab 2019;
"Laboratory medicine in different countries" and "Laboratory Indicators", 53rd
CBPC/ML
Experience in Clinical Research Studies:
Evaluation of Thrombin Generation in Patients undergoing Direct Oral Anticoagulant
Therapy
Lp-PLA2 (lipoprotein-associated phospholipase A2) levels in patients with
cardiovascular disease and stroke
Clinical validation of the Horiba Medical new coagulation instrument: YUMIZEN G1550
Clinical validation of the Body fluid cycle (CBF) of the Horiba Medical new hematology
instrument: YUMIZEN H2500
SKYSCRAPER07, Clinical Trial
AUR87A, Clinical Trial
OASIS-2, Clinical Trial
Herizon, Clinical Trial
Sunday, June 25, 2023
18:30 – 19:30 ET
Monday, June 26, 2023
18:30 – 19:30 ET